Opal Therapeutics Inc.
San Francisco, CA
- UEI
- XM2SWPGL7EG4
- CAGE
- Not on record
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 135 Mississippi St, San Francisco, CA 94107, USA
- Website
- opaltherapeutics.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase II: scaling platforms for translational research and therapeutic screening -the broader impact /commercial… | National Science Foundation | $1,250,000 | |
| Sbir phase i: AI-driven protac drug discovery - pioneering non-hormonal therapeutic targets for uterine fibroids and… | National Science Foundation | $295,000 |
Quick answers
What is Opal Therapeutics Inc.'s UEI?
Opal Therapeutics Inc.'s Unique Entity ID (UEI) in SAM.gov is XM2SWPGL7EG4.
Where is Opal Therapeutics Inc. located?
Opal Therapeutics Inc.'s physical address in SAM.gov is 135 Mississippi St, San Francisco, CA 94107, USA.
Is Opal Therapeutics Inc. registered in SAM.gov?
Yes. Opal Therapeutics Inc.'s SAM.gov registration is active through May 18, 2027.
What is Opal Therapeutics Inc.'s most recent federal award?
Opal Therapeutics Inc.'s most recent federal grant award is Sbir phase II: scaling platforms for translational research and therapeutic screening -the broader impact /commercial… (2605008), from National Science Foundation, on August 1, 2026.
On GovTribe
See Opal Therapeutics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors